Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents.
作者信息
Tucci Marcello, Roca Elisa, Ferrari Laura, Pia Anna, Dalla Volta Alberto, Bedussi Francesca, Buttigliero Consuelo, Vittorio Scagliotti Giorgio, Sigala Sandra, Berruti Alfredo
机构信息
Medical Oncology, Cardinal Massaia Hospital, Corso Dante Alighieri, 202, 14100, Asti, Italy.
Medical Oncology, ASST-Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
出版信息
Endocrine. 2019 Jun;64(3):724-726. doi: 10.1007/s12020-019-01947-4. Epub 2019 May 7.
PMID:31065911
Abstract
摘要
Zotero 插件